Drug Type Small molecule drug |
Synonyms 24-Ketocholesterol |
Target |
Mechanism LXR-α agonists(nuclear receptor subfamily 1 group H member 3 agonists), NR1H2 stimulants(nuclear receptor subfamily 1 group H member 2 stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiovascular Diseases | Preclinical | CN | 09 Jan 2023 | |
Cardiovascular Diseases | Preclinical | NL | 09 Jan 2023 | |
Neurodegenerative Diseases | Preclinical | NL | 09 Jan 2023 | |
Neurodegenerative Diseases | Preclinical | CN | 09 Jan 2023 |